Search results
Results from the WOW.Com Content Network
In the wake of last week’s election, many young women are coming to terms with their new reality: reproductive rights, and access to sexual and reproductive health care, will almost certainly be ...
The World Health Organization considers the rhythm method to be a specific type of calendar-based method, and calendar-based methods to be only one form of fertility awareness. [2] More effective than calendar-based methods, systems of fertility awareness that track basal body temperature, cervical mucus, or both, are known as symptoms-based ...
The Reproductive Health Access Project, Inc. (RHAP) is a nonprofit organization that seeks to integrate abortion, contraception, ...
Calendar-based methods [29] The rhythm method, Knaus-Ogino method, Standard Days method: no data: 5 (1 in 20) Behavioral: Calendar-based: Daily: Plastic contraceptive sponge with spermicide used by parous [38] [note 5] Today sponge, the sponge: 27 (1 in 3.7) 20 (1 in 4) Barrier & spermicide: Vaginal insertion: Every act of intercourse ...
On November 5, abortion access and reproductive rights will be top of mind for millions of voters as they head to the polls to determine the next president of the United States.
DMPA, under brand names such as Depo-Provera and Depo-SubQ Provera 104, is used in hormonal birth control as a long-lasting progestogen-only injectable contraceptive to prevent pregnancy in women. [ 38 ] [ 39 ] It is given by intramuscular or subcutaneous injection and forms a long-lasting depot , from which it is slowly released over a period ...
Based on the three data categories outlined above, here are all 50 states ranked from most to least access when it comes to providing reproductive health care access for men. 1. Delaware. 2 ...
Depot MPA (DMPA) and EC/MPA were developed by Upjohn in the 1960s. [12] [13] DMPA (brand name Depo-Provera) was introduced for use as a progestogen-only injectable contraceptive for the first time outside of the United States in 1969 and was subsequently approved for use in birth control in the United States in 1992.